Patents by Inventor Katalin Urban-Szabo

Katalin Urban-Szabo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050130981
    Abstract: The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms.
    Type: Application
    Filed: March 4, 2003
    Publication date: June 16, 2005
    Inventors: Peter Aranyl, Laszlo Balazs, Imre Bata, Sandor Batori, Eva Boronkay, Philippe Bovy, Karoly Kanai, Zoltan Kapui, Edit Susan, Tibor Szabo, Lajos Nagy, Katalin Urban-Szabo, Marton Varga
  • Publication number: 20050124648
    Abstract: The present invention relates to adenosine A-3? receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and theirs salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.
    Type: Application
    Filed: December 17, 2002
    Publication date: June 9, 2005
    Inventors: Peter Aranyi, Laszlo Balazs, Sandor Batori, Judit Bence, Kinga Boer, Felix Hadju, Zoltan Kapui, Endre Mikus, Tibor Szabo, Lajos T. Nagy, Geza Timari, Katalin Urban-Szabo, Erzsebet Walcz
  • Publication number: 20050070566
    Abstract: The present invention relates to adenosine A3 receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and (heir salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and (III) and to the preparation thereof.
    Type: Application
    Filed: December 17, 2002
    Publication date: March 31, 2005
    Inventors: Peter Aranyl, Laszlo Balazs, Maria Balogh, Sandor Batori, Kinga Boer, Katalin Gerber, Zoltan Kapui, Endre Mikus, Geza Timari, T. Lajos, Katalin Urban-Szabo, Judit Vargane Szeredi
  • Publication number: 20040186133
    Abstract: Compounds of general formula (I), wherein R4 and R5 stand for hydrogen atom or form together an 1,3-butadienyl group, optionally substituted by a methylenedioxy group or one or more straight or branched C1-4 alkyl group, straight or branched C1-4 alkoxy group, hydroxy group or halogen atom; are strong adenosine A3 receptor ligands preferably antagonists.
    Type: Application
    Filed: May 13, 2004
    Publication date: September 23, 2004
    Inventors: Peter Aranyl, Laszlo Balazs, Maria Balogh, Imre Bata, Sandor Batori, Lajos T. Nagy, Geza Timari, Kinga Boer, Olivier Finance, Zoltan Kapul, Endre Mikus, Zsuzsanna Szamosvolgyi, Gabor Szeleczky, Katalin Urban-Szabo
  • Publication number: 20030114449
    Abstract: Orally active compounds of general formula (I) wherein R1 is methyl, ethyl or 2-morpholino-ethyl group, R2 is piperidino, morpholino or 4-methyl-piperazinyl group, n is 2 or 3 and their salts, solvates and hydrates.
    Type: Application
    Filed: October 7, 2002
    Publication date: June 19, 2003
    Inventors: Peter Aranyi, Sandor Batori, Stephane Dessilla, Istvan Hermecz, Zoltan Kapui, Ferenc Levai, Endre Mikus, Marc Pascal, Lajos T. Nagy, Bruno Simonot, Katalin Urban Szabo, Marton Varga, Lelle Vasvarine Debreczy